对参与慢性炎症的病毒和真菌蛋白及其生物治疗方法的结构和功能洞察
Mohamed Halawa1, Alicia L Gallo1, Valerie J Carabetta1
1Department of Biomedical Sciences, Cooper Medical School, Rowan University, Camden, NJ 08103, USA.
Pharmaceutics
|November 27, 2025
概括
病毒和真菌感染导致的慢性炎症与癌症和自身免疫性疾病有关. 针对这些感染的生物疗法在治疗炎症和相关疾病方面表现有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 传染性疾病 传染性疾病
背景情况:
- 慢性炎症是持续性病毒和真菌感染的标志,有助于癌症,自身免疫疾病和纤维化.
- 病毒蛋白 (例如,HIV-1 Tat,HBx,HPV E6/E7,EBV LMP1) 激活了像NF-κB这样的免疫信号通路,创造了一个促炎环境.
- 真菌蛋白 (例如Saps,Asp f1,基结合蛋白) 通过模式识别受体和炎症酶激活触发炎症.
研究的目的:
- 提供对病毒和真菌炎症蛋白质的结构和功能见解.
- 评估生物药物对与感染相关的慢性炎症的治疗潜力.
- 讨论正在进行的临床试验和生物疗法的局限性.
主要方法:
- 对病毒和真菌炎症蛋白质的结构和功能数据的审查.
- 分析潜在的宿主-病原体相互作用的分子机制.
- 评估生物疗法,包括和单克隆抗体.
- 讨论临床试验数据和生物信息分析.
主要成果:
- 病毒蛋白调节宿主免疫信号,促进炎症,免疫逃避和瘤发生.
- 蛋白激活先天免疫受体,导致慢性炎症.
- 结构和生物信息学研究揭示了这些蛋白质中的关键宿主相互作用动机.
- 生物学家提供有针对性的方法来破坏炎症途径.
结论:
- 病毒和真菌蛋白质是感染中慢性炎症的关键驱动因素.
- 生物疗法,包括抗体和,代表了有前途的干预措施.
- 需要进一步的研究和临床试验来克服局限性,并将生物制剂转化为实践.
相关概念视频
Microorganisms in Medicine and Therapeutics
920
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Inflammatory Response
15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K
Viral Structure
73.7K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
73.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
465
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
465
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Inflammation
61.5K
Overview
61.5K


